Lexington, SC, United States of America

Mengqian Chen

USPTO Granted Patents = 4 

 

 

Average Co-Inventor Count = 3.7

ph-index = 2

Forward Citations = 5(Granted Patents)


Location History:

  • Columbia, SC (US) (2017)
  • Lexington, SC (US) (2021 - 2023)

Company Filing History:


Years Active: 2017-2025

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Inventor Profile: Mengqian Chen

Introduction

Mengqian Chen is an innovative inventor based in Lexington, South Carolina, known for his contributions to cancer therapy through the development of novel chemical compounds. He holds three patents that showcase his research and applications in this critical field of medicine.

Latest Patents

Mengqian Chen's latest patents include two significant contributions to cancer treatment methodologies. The first patent, titled "Bicyclic pyridine compositions and methods of using the same for cancer therapy," discloses various bicyclic pyridines, including thienopyridine, pyrrolopyridine, and furopyridine compounds. These compounds are specifically designed for treating cancers, reflecting Chen's dedication to advancing therapeutic options.

The second patent, "Quinoline-based compounds and methods of inhibiting CDK8/19," focuses on a class of quinoline-based compounds aimed at inhibiting CDK8 and CDK19, which play critical roles in several diseases and disorders. This patent discusses the pharmaceutical compositions comprising substituted quinoline compounds that function effectively against CDK8/19-associated conditions, further emphasizing Chen’s impact on medical research.

Career Highlights

Mengqian Chen has made significant strides in his career, specifically through his work at noteworthy institutions. He has been affiliated with the University of South Carolina, contributing to both academic advancement and research. Additionally, Chen has been associated with Senex Biotechnology, Inc., a company known for its focus on innovative biotechnological solutions.

Collaborations

Throughout his career, he has collaborated with distinguished professionals, including Igor B. Roninson and Campbell McInnes. These partnerships highlight his strong connections within the scientific community and his commitment to pushing the boundaries of cancer research.

Conclusion

Mengqian Chen represents a vital force in the realm of medical innovation, particularly in cancer treatment. His patents reflect a profound understanding of chemical compounds and their potential applications in overcoming significant health challenges. Through his work with reputable institutions and collaborations with other experts, Chen continues to pave the way for advancements in cancer therapy.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…